A Study of Thinprep Cytologic Test Combined with Human Papilloma Virus Hybrid CaptureⅡ DNA Test and Biopsy-Control in Cervical Lesions

TAO Kun,YANG Jing,YANG Hua,GUO Zhenhua,CHEN Xiangyu,MENG Xiaoyan,WANG Chunlei,TANG Longying,ZUO Xulei
DOI: https://doi.org/10.3969/j.issn.1008-6358.2011.02.024
2011-01-01
Abstract:Objective:To investigate the value of thinprep cytologic test(TCT) combined with human papilloma virus(HPV) Hybrid Capture II(HPV HCII) test in cervical intraepithelial neoplasia and summarize the reasons for misinterpreting/missing diagnosis.Methods:Patients(n=1050) with TCT,HCII HPV test and routine biopsy under colposcopy encountered between 2006-2009 in Shanghai Changning District hospital.According to cervical biopsy diagnosis,we analyzed the causes of false-positive and false-negative in TCT diagnosis and compared the diagnostic efficiency among TCT,HCII HPV test,TCT combined with HCII HPV test.Results: The rates of(LSIL/HSIL) accordance with biopsy were higher than(NILM/ASCUS),P0.01.HPV infection was increased with the degree of cervical lesions(P0.01).The sensitivity and negative predictive value were significantly higher for TCT combined with HCII HPV DNA than TCT alone(P0.01).The causes of false-positive in TCT diagnosis were mainly for misinterpreting reactive cells and regressive cells while false-negative were mainly for missing individual koilocyte and dysplastic cell.Conclusions: TCT combined with HCII HPV test evidently enhance diagnostic efficiency which will play a positive role in the early preventation,detection and treatment of cervical carcinoma.False-positive and false-negative will be effectively decreased by means of accurate sampling,regular procession and exact recognization of reactive cell,koilocyte and hyperchromaticly dysplastic cell.
What problem does this paper attempt to address?